Love him or hate him, Jim Cramer does not often bl
Post# of 15624
(Total Views: 388)
Posted On: 04/12/2017 6:57:15 PM
Love him or hate him, Jim Cramer does not often bless speculative stocks like preclinical biotechs. Cramer just surprised me by saying he'd buy a bit of INCY now, and more after a secondary offering is priced, BASED largely on INCY's vast PIPELINE.
Wow, Dr. Cramer is turning over a new leaf!
For those of you who don't know much about INCY, it trades at around $130 a share, has a market cap of $27 Billion, earnings of around a Billion in 2016, and trades at a whooping 250 PE.
As a reminder, OWCP has a very strong pipeline which will IMHO fly through FDA approvals. We all know cannabinoids are effective and safe.
OWCP's Pipeline includes Psoriasis, other skin disorders, PTSD, Migraines, and Multiple Myeloma. OWCP's Pipeline also includes four delivery systems which the company fully intends to license.
OWCP- Know What You Own!
Wow, Dr. Cramer is turning over a new leaf!
For those of you who don't know much about INCY, it trades at around $130 a share, has a market cap of $27 Billion, earnings of around a Billion in 2016, and trades at a whooping 250 PE.
As a reminder, OWCP has a very strong pipeline which will IMHO fly through FDA approvals. We all know cannabinoids are effective and safe.
OWCP's Pipeline includes Psoriasis, other skin disorders, PTSD, Migraines, and Multiple Myeloma. OWCP's Pipeline also includes four delivery systems which the company fully intends to license.
OWCP- Know What You Own!
(0)
(0)